ViaGen Pets

What ViaGen Pets does

ViaGen Pets is a privately held animal cloning and genetic preservation company operating in Cedar Park / Whitesboro, Texas with additional offices in Ocala, Florida and Lethbridge, Canada. The company uses somatic cell nuclear transfer (SCNT) — under an exclusive license to the Roslin Institute's patent portfolio that traces back to the Dolly the sheep technology — to produce genetically identical clones of dogs, cats, horses, and livestock, alongside cryopreservation and biobanking services. ViaGen reports an 80% cloning efficiency rate and a cumulative track record of over 2,000 animals cloned across 15 species, including more than 1,000 cloned foals and endangered species work such as Elizabeth Ann (the first cloned black-footed ferret) and the first cloned Przewalski's horse.

The company's revenue model is concentrated on high-value, one-time transactions: pet cloning at $50,000 per dog or cat, horse cloning at $85,000, and a $1,600 Genetic Preservation service that cryopreserves cells for future cloning, with recurring storage fees. Customers fall into three primary segments — affluent companion-animal owners served through a direct-to-consumer website, phone sales, and a 500+ veterinarian referral network; elite equine breeders purchasing cloning, ICSI, and sexed semen services; and conservation institutions including the San Diego Zoo Wildlife Alliance and the U.S. Fish and Wildlife Service for endangered-species work.

In November 2025, ViaGen was acquired by Colossal Biosciences, a Dallas-based de-extinction company valued at $10 billion, and now operates as a wholly owned subsidiary contributing reproductive services, cryopreservation, and cell banking to Colossal's broader conservation platform. The business has a 5-month waitlist on pet cloning, indicating demand exceeds current lab throughput.

Name

ViaGen Pets

Legal name

Viagen

Website

https://viagenpets.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

ViaGen Pets is a Texas-based animal cloning and genetic preservation company that produces SCNT-based clones of dogs, cats, and horses for affluent owners and elite breeders, and partners with conservation institutions on endangered species cloning.

Ownership category

akta.pro rank

Product category

Animal Cloning Services

NAICS

Support Activities for Animal Production (1152)

SIC

Agricultural Services (700)

akta.pro primary industry

Companion/Specialty Animal Breeding & Genetics Services (non-livestock) (AFAEAJAO)

Keywords

• Pet cloning services
• Equine cloning
• Genetic preservation
• Animal biotechnology
• Somatic cell nuclear transfer

Headquarters

HQ city

Cedar Park

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pet Cloning Services: One-time high-value cloning services for dogs and cats at $50,000 each, paid in two equal installments. Revenue recognized upon successful delivery of cloned animals.
2. Equine Cloning Services: Horse cloning at $85,000, paid in two equal installments. Targets elite performance horse owners and breeders preserving champion genetics.
3. Genetic Preservation Services: $1,600 one-time fee for dog/cat genetic preservation including cell culture and cryopreservation. Optional recurring storage fees.
4. Storage and Maintenance Fees: Ongoing storage fees for Genetic Preservation clients, including payments for storage fees through the online payment portal.
5. ICSI and Sexed Semen Services: Additional equine reproductive services including ICSI and sexed semen processing, with separate contract pricing.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

ViaGen Pets is an animal biotechnology company that provides cloning and genetic preservation services for companion animals, performance horses, and endangered species. Core services include dog and cat cloning at $50,000, horse cloning at $85,000, genetic preservation cryopreservation at $1,600, and conservation cloning delivered through Somatic Cell Nuclear Transfer (SCNT) technology licensed from the Roslin Institute.

Product overview

ViaGen Pets is a pet and equine cloning company offering a comprehensive suite of genetic preservation and reproductive biotechnology services. The core offerings include pet cloning (dogs and cats at $50,000) and equine cloning ($85,000), supported by Genetic Preservation ($1,600) and Express Tissue Banking modules for long-term cell storage. Equine-specific services include ICSI and Sexed Semen sub-products. The company also maintains a Veterinary Network for biopsy support and partners with conservation organizations including the San Diego Zoo and U.S. Fish and Wildlife for endangered species preservation. ViaGen operates as a subsidiary of Colossal Biosciences following acquisition in November 2025.

Differentiator

Problem solved

Functional benefit

Products and services

• Pet Cloning Services Service enabling pet owners to create genetically identical clones of their dogs and cats using somatic cell nuclear transfer, priced at $50,000 per animal.
• Equine Cloning Services Horse cloning services that reproduce elite equine genetics, allowing owners to preserve champion bloodlines and performance genetics, priced at $85,000 per clone.
• Genetic Preservation (GP) Cryopreservation service that cultures and stores live cells from pet tissue samples, enabling future cloning options. Priced at $1,600 for dogs and cats.
• Express Tissue Banking (ETB) Lower-cost alternative to full genetic preservation that stores pet tissue samples without developing new cells, for potential future cloning use.
• ICSI (Intracytoplasmic Sperm Injection) Services Advanced equine fertility service involving injection of a single sperm cell into a mature oocyte, particularly beneficial for high-performance horses, older or lame mares, and limited semen situations.
• Sexed Semen Services Gender-sorted semen service providing greater than 95% accuracy when combined with ICSI, allowing equine breeders to select desired gender for breeding programs.
• Genetic Inventory & Semen Storage Semen storage and inventory management services for stallions, including stored semen and sexed semen options for use with ICSI programs.
• Conservation & Species Preservation Wildlife conservation cloning services partnering with institutions like San Diego Zoo Wildlife Alliance and U.S. Fish and Wildlife Service to preserve endangered species including black-footed ferret, Przewalski's horse, and other threatened animals.

Quantifiable outcome

• 80% cloning efficiency rate
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Six partnerships are on record, tiered core and key.

• Colossal BiosciencescoreStrategic or Co-development Partner · 6 November 2025Colossal Biosciences acquired ViaGen Pets & Equine in November 2025, integrating reproductive services, cryopreservation, and cell banking into Colossal's conservation platform. ViaGen operates as a wholly owned subsidiary while continuing pet, equine, and livestock services. The acquisition strengthens Colossal's end-to-end toolkit spanning ancient DNA assembly, comparative genomics, genome engineering, and assisted reproduction.
• Roslin InstitutecoreOEM/ Whitelabel/ Licensing PartnerExclusive licensee of the Roslin Institute's SCNT patent portfolio. Successfully commercialized somatic cell nuclear transfer for multiple species, including elite performance horses. The Roslin Institute is the organization that created Dolly the sheep.
• San Diego Zoo Wildlife AlliancecoreStrategic or Co-development PartnerLong-standing partnership for conservation cloning. Contributed to first cloned black-footed ferret (Elizabeth Ann, born December 2020) and first cloned Przewalski's horse (born August 2020 from 1980 DNA). Active collaboration on BioVault initiatives.
• U.S. Fish and Wildlife ServicecoreStrategic or Co-development PartnerPartnership for black-footed ferret conservation program. Elizabeth Ann, the first cloned black-footed ferret, was produced in collaboration with USFWS to address severe genetic inbreeding in the reintroduced population of 400-500 individuals.
• Sexing TechnologieskeyTechnology or IntegrationPartnership for gender-sorted sperm services. Viagen works with Sexing Technologies to offer sex-sorted semen with greater than 95% accuracy when combined with ICSI program.
• Colossal FoundationcoreStrategic or Co-development PartnerViagen works alongside the Colossal Foundation to bring advanced science to frontline conservation efforts. Partnership focuses on BioVault initiatives and scaling conservation cloning globally across 42+ biobanked species.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Revive & Restore: Conservation nonprofit advancing genetic rescue, biobanking, and cloning for endangered species. Closely adjacent to ViaGen's conservation/BioVault work and a collaborator in the wildlife cloning ecosystem.
• Embark Veterinary: Consumer dog DNA testing and breed identification company. Adjacent to ViaGen's pet genetic preservation business, focused on consumer genetic insights rather than reproductive cloning or cryopreservation.
• Wisdom Panel: Pet DNA testing service owned by Mars Petcare, offering breed identification and health screening. Operates in the consumer pet genetics space adjacent to ViaGen's genetic preservation offerings.
• Gemini Genetics: UK-based equine cloning and cryopreservation company offering horse cloning services comparable to ViaGen Equine. Directly competes in the elite equine cloning market, especially across European clients.

Broad incumbents

• Zoetis: Largest global animal health company offering genetics, reproductive pharmaceuticals, and breeding technologies. Operates in adjacent animal reproductive and genetic services rather than direct cloning competition.

Direct peers

• Sooam Biotech: South Korean biotech firm and the world's only other commercial-scale dog cloning provider, directly competing with ViaGen for global pet cloning customers using comparable SCNT technology.
• Sinogene: Beijing-based pet cloning company offering commercial dog and cat cloning services. Direct competitor to ViaGen in the global companion animal cloning market with similar Somatic Cell Nuclear Transfer capabilities.

Others

• Sexing Technologies: Animal genetics company specializing in sexed semen sorting. Existing ViaGen partner for equine sexed semen services, operating in the adjacent equine reproductive technology ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ViaGenPets
• YouTubeyoutube.com/channel/UCuVPsZTPtMMTa5oC1pEZv_Q
• Facebookfacebook.com/ViaGenPets
• Instagraminstagram.com/viagenpetsandequine
• LinkedInlinkedin.com/company/viagen

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ViaGen Pets